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G protein-coupled receptors (GPCRs) coupling to
Gi/o signaling pathways are involved in the control
of important physiological functions, which are diffi-
cult to investigate because of the limitation of tools to
control the signaling pathway with precise kinetics
and specificity. We established two vertebrate cone
opsins, short- and long-wavelength opsin, for long-
lasting and repetitive activation of Gi/o signaling
pathways in vitro and in vivo. We demonstrate for
both opsins the repetitive fast, membrane-delimited,
ultra light-sensitive, andwavelength-dependent acti-
vation of the Gi/o pathway in HEK cells. We also show
repetitive control of Gi/o pathway activation in 5-HT1A
receptor domains in the dorsal raphe nucleus (DRN)
in brain slices and in vivo, which is sufficient tomodu-
late anxiety behavior in mice. Thus, vertebrate cone
opsins represent a class of tools for understanding
the role of Gi/o-coupledGPCRs in health and disease.
INTRODUCTION
G protein-coupled receptors (GPCRs) represent the major pro-
tein family for the conversion of extracellular cues into intracel-
lular signals. GPCRs couple mainly to three signaling pathways,
i.e., Gi/o, Gq, and Gs. Among them, the Gi/o pathway is involved in
various signaling processes including the fast dampening of
neuronal activity via activation and inhibition of ion channels
(e.g., K+ or Ca2+ currents) and the slow modulation of enzymatic
cascades (e.g., adenylyl cyclase and extracellular signal regu-
lated kinase [ERK]). Important transmitters systems and GPCRs
activating the Gi/o pathway are, for example, GABA (GABAB-
receptors), endocannabinoids (CB1-receptors), and serotonin
(5-HT1-receptors) representing important drug targets for
different brain diseases. Unfortunately, current drugs andmolec-
ular tools available to investigate andmanipulate theseGPCRs in
health and disease have various limitations for example in GPCR
and/or pathway specificity, in the precise control of the activa-tion and deactivation kinetics of the GPCR pathway, and in the
subcellular-specific control of the GPCR pathway in a defined
neuronal circuit. In order to overcome these problems, we devel-
oped optogenetic tools, the vertebrate cone opsins, for fast,
repetitive, and ultra light-sensitive control of Gi/o pathways in
specific receptor domains, such as the 5-HT1 receptors, in vivo
without supply of any external ligands.
5-HT1 receptors act as so-called autoreceptors in seroto-
nergic neurons and as heteroreceptors in non-5-HT neurons to
modulate serotonergic tone (McDevitt and Neumaier, 2011;
Sharp et al., 2007). Among them, the 5-HT1A receptor is the
most prominent receptor localized on somatodendritic areas of
5-HT and nonserotonergic neurons within the DRN and has
been implicated in a variety of psychiatric disorders including
anxiety and depression (Sharp et al., 2007). To understand
the precise function of 5-HT1A receptors and in general other
Gi/o-coupled GPCRs, it will be important to repetitively and pre-
cisely control 5-HT1A receptor signaling cascades in cells and
subcellular compartments where 5-HT1A receptors are located
(i.e., 5-HT1A receptor domains) or GPCR-specific domains over
long time periods in vivo.
In recent years, various approaches have been developed to
control GPCR signaling. These approaches include chemical
and optogenetic approaches such as DREADDs, RASSLS, engi-
neered GPCRs for binding of light-activated ligands, and verte-
brate and invertebrate rhodopsin/opsins (Armbruster et al.,
2007; Herlitze and Landmesser, 2007; Masseck et al., 2011).
DREADDs and RASSLS use chemically inert ligands where the
activation of the signaling pathways is difficult to control tempo-
rally. Engineered GPCRs tethered to light-activatable ligands,
such as the recently developed LimGluR2 (Levitz et al., 2013)
are limited by the fact that a photoactivatable ligand has to be
applied, which will be difficult to supply in particular in the
mammalian brain. Vertebrate rhodopsin has the disadvantage
that sustained and repetitive GPCR activation leads to a decline
in signaling response (Levitz et al., 2013).
In order to overcome this problem and to further develop the
use of Gi/o-coupled light-activated GPCRs in neurons we used
two opsins from the vertebrate eye involved in color vision, i.e.,
the short- and long-wavelength opsin (vSWO and vLWO), which
have been used in cultured cells to control slow Gi/o signals (Kar-
unarathne et al., 2013). We found that fast, membrane-delimitedNeuron 81, 1263–1273, March 19, 2014 ª2014 Elsevier Inc. 1263
Figure 1. Repetitive Activation and Deacti-
vation of GIRK Currents in HEK293 Cells
without Decline in Response Amplitude by
Short- and Long-Wavelength Opsin
(A) Comparison of GIRK channel current traces
activated by vRh (top), vSWO (middle), and vLWO
(bottom) using 1 s light pulses of 475 nm, 450 nm,
and 590 nm light, respectively.
(B) Comparison of the maximal GIRK current
response during repetitive light stimulation for
currents activated by vRh (black), vSWO (white),
vSWO5-HT1A (white box, shown for relative GIRK
current after the 20th trial), vLWO (dark gray), and
vLWO5-HT1A (gray box, shown for relative GIRK
current after the 20th trial) using 1 s light pulses
of 475 nm (vRh), 450 nm (vSWOs), and
590 nm (vLWOs) light, respectively. For vSWO,
vSWO5-HT1A, vLWO and vLWO5-HT1A GIRK cur-
rents do not decline over time (n = 10 for vSWO,
vLWO; n = 5 for vSWO5-HT1A, vLWO5-HT1A).
(C) Comparison of activation time constants for
GIRK current activation by vRh (black), vSWO
(white), vSWO5-HT1A (light gray), vLWO (dark gray),
and vLWO5-HT1A (medium gray) after a 1 s light
pulses of 475 nm (vRh), 450 nm (vSWOs), and
590 nm (vLWOs) light, respectively.
(D) Comparison of deactivation time constants for
GIRK current deactivation by vRh (black), vSWO
(white), vSWO5-HT1A (light gray), vLWO (dark gray),
and vLWO5-HT1A (medium gray) after 1 s light pulses of 475 nm (vRh), 450 nm (vSWOs), and 590 nm (vLWOs) light, respectively.
(E) Comparison of theGIRK current amplitudes activated by vRh (black), vSWO (white), vSWO5-HT1A (light gray), vLWO (dark gray), and vLWO5-HT1A (medium gray)
after a 1 s light pulses of 475 nm (vRh), 450 nm (vSWOs), and 590 nm (vLWOs) light, respectively. Numbers in parenthesis indicate the numbers of experiments.
Values are given as mean ± SEM; **p < 0.01, ***p < 0.001 ANOVA; light intensity 2 mW/mm2.
See also Figures S1 and S3.
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Control of Gi/o Signaling by Cone Opsinsintracellular Gi/o signals activated by the vertebrate opsins in
comparison to rhodopsin do not decline in amplitude during re-
petitive stimulation and can be sustained for minutes. The light
sensitivity for vertebrate rhodopsins/opsins is much higher in
comparison to other optogenetic tools such as the ultra light-
sensitive ChR2 variant CatCh and the halorhodopsin variant
eNpHR 3.0 were maximally activated at 2 mW/mm2 (Kleinlogel
et al., 2011;Gradinaru et al., 2010) contributing to a superb in vivo
performance. Indeed, vertebrate cone opsins can be used for
repetitive Gi/o activation in vivo without application of any further
ligands and are suitable to control emotional behavior in mice.
Therefore, vSWO and vLWO are tools for the control of neuronal
Gi/o signaling pathways in vivo and represent the tools of choice
to understand and dissect the function of Gi/o signals in health
and disease.
RESULTS
Repetitive Activation of vLWO and vSWO in a
Heterologous Expression System
Recently, we established vRh as a tool to control the Gi/o
signaling pathway in vitro and in vivo (Gutierrez et al., 2011;
Li et al., 2005; Oh et al., 2010). vRh has the limitation that
light-induced signaling responses decline during repetitive
stimulation (Figures 1A and 1B) (Levitz et al., 2013). In order to
overcome this problem, we tested different vertebrate opsins
from the human and mouse eye involved in color vision, i.e.,1264 Neuron 81, 1263–1273, March 19, 2014 ª2014 Elsevier Inc.vSWO (mouse) and vLWO (human) opsins for their capabilities
to modulate GIRK channel activity repetitively and over long
time periods.
GIRK channels are modulated in a membrane-delimited, fast
manner via the Gi/o pathway (Hille, 1994; Mark and Herlitze,
2000). We compared the amplitudes and kinetics of light-
induced activation and deactivation of GIRK channels between
vSWO, vLWO, and vRh when expressed in HEK293 cells stably
expressing GIRK1/2 subunits (kindly provided by Dr. A. Tinker,
UCL). We found that vSWO, vLWO, and vRh induced large
GIRK current amplitudes during a 1 s, 2 mW/mm2 light pulse
(i.e., 450 nm, 590 nm, and 475 nm, respectively) (Figures 1A
and 1E). Repetitive 1 s long light stimulation of GIRK currents
did not decline in amplitude for light activation of vSWO and
vLWO during 20 trials (20 min, Figures 1A and 1B). In com-
parison, GIRK current amplitude declined to 20% of the
original amplitude elicited by the first light pulse when vRh was
coexpressed (Figures 1A and 1B). In addition, GIRK channel acti-
vation and deactivation kinetics were faster whenGIRK channels
were activated by the cone opsins in comparison to vRh (Figures
1C and 1D). As previously shown for vRh, vSWO and vLWO do
not activate GIRK currents in the absence of light suggesting
that leak activity in the dark is minimal (Figure S1 available online)
(Oh et al., 2010). In addition, fusion of the C terminus (CT) of the
5-HT1A receptor to the CT of themCherry or eGFP-tagged vSWO
or vLWO does not change the light activation properties of the
vertebrate opsins (Figures 1B–1E).
Figure 2. Light-Intensity Dependence, Activation Kinetics, and Long-Term Stimulation of Vertebrate Opsins
(A) Light intensity dependence of GIRK current activation by vRh, vSWO, and vLWO using a 1 s light pulse of 470 nm, 400 nm, and 590 nm, respectively (n = 5).
(B) Light duration dependence of maximal GIRK current activation induced by vRh, vSWO, and vLWO using a light pulse of the indicated duration of 470 nm,
400 nm, and 590 nm (n = 5).
(C) Left: example traces of normalized light-induced GIRK currents by vRh, vSWO, and vLWO using a 1 s (0.02 mW/mm2) long light pulse. Middle and right: light
pulse-dependent time course of light-induced GIRK current activation (middle) and deactivation (right) induced by vRh, vSWO, and vLWO using a light pulse of
the indicated duration of 470 nm, 400 nm, and 590 nm (n = 3–5). Activation and deactivation constants (t) were determined by a single exponential fit.
(D) Example traces of long-term (60 s, 0.02 mW/mm2), light-induced GIRK currents by vRh, vSWO, and vLWO.
(E) Remaining GIRK current after a 60 s light stimulation of vRh, vSWO, and vLWO in percent.
(F) Time course of decline in GIRK current during light activation. Decline in GIRK current was determined by a single exponential fit. Numbers in parenthesis
indicate the numbers of experiments. Values are given as mean ± SEM; *p < 0.05, **p < 0.01 ANOVA.
See also Figures S2–S4.
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Control of Gi/o Signaling by Cone OpsinsThus, vSWO and vLWOcan be used to repetitively activate the
Gi/o pathway with fast kinetics and without decline in response
amplitude.
Intensity Dependence, Activation Kinetics, and
Long-Term Stimulation of vOpsins
We next tested the light-intensity dependence of vRh-, vSWO-,
and vLWO-mediated GIRK current activation. For all threelight-activated GPCRs light-induced GIRK currents were largest
around 0.02mW/mm2 (Figure 2A). Dimmer light (0.002mW/mm2)
was still sufficient to activate around 20% (vSWS), 30% (vRh),
or 70% (vLWO) of the maximal GIRK current. Interestingly,
light-induced GIRK currents decreased with light intensities
>0.02 mW/mm2 suggesting that at high light intensities a certain
percentage of rhodopsins and opsins are bleached and/or
desensitized (Figures S2 and S3). In comparison, the ultraNeuron 81, 1263–1273, March 19, 2014 ª2014 Elsevier Inc. 1265
Figure 3. Spectral Tuning of Blue and Red Vertebrate Opsins
(A) Blue and red vertebrate opsins have different absorption maxima. vSWO
has its absorption maximum around 380–400 nm. vLWO has an absorption
maximum around 600 nm. Ten second light pulses of different wavelengths
(380–650 nm in 10 nm steps; light intensities 0.02 mW/mm2) were applied, and
normalized GIRK currents were calculated for each individual cell (mean ±
SEM; n = 5).
(B) Relative GIRK currents induced by vSWO and vLWO at different light-
intensities at 400 nm and 600 nm light. One second 400 nm and 600 nm light
pulses of the indicated light-intensities were applied and GIRK currents were
normalized to the largest current elicited with 0.02 mW/mm2 light (mean ±
SEM; n = 5).
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Control of Gi/o Signaling by Cone Opsinslight-sensitive ChR2 variant CatCh and the halorhodopsin variant
eNpHR 3.0 were maximally activated at 2 mW/mm2 (Figure S4)
(Kleinlogel et al., 2011; Gradinaru et al., 2010). This suggests
that light activation of vSWO and vLWO is very sensitive in com-
parison to other ChR and halorhodopsin variants. Therefore,
vSWO and vLWO should be suitable for light activation of Gi/o
signaling cascades in deep brain areas in vivo.
Subsequently, we investigated the light-time dependence of
GIRK channel activation at 0.02 mW/mm2 light-intensity (Fig-
ure 2B). We found that for all three light-activated GPCRs 1 s
light pulses are necessary and sufficient to activate the
maximal GIRK current. To activate around 50% of maximal
GIRK current 50 ms light pulses were sufficient for vRh,
200 ms for vLWO, and 500 ms for vSWO. GIRK current activa-
tion became faster with increasing light duration, while GIRK
current deactivation was independent of the light pulse dura-
tion (Figure 2C). During 60 s long light stimuli, GIRK current
declined to a steady state to 70% (vLWO), 78% (vSWO), and
73% (vRh) of the maximal light-activated GIRK current (Figures
2D and 2E), which is faster for vLWO in comparison to vSWO
and vRh (Figure 2F).1266 Neuron 81, 1263–1273, March 19, 2014 ª2014 Elsevier Inc.Spectral Tuning of vOpsins
The mouse blue SWS1 opsin (OPN1SW) has an absorption
maximum of 360 nm while the human M/LWS opsin (OPN1LW)
has its absorption maximum between 550–560 nm (Ebrey and
Koutalos, 2001). We reasoned that an important potential use
of vSWO and vLWO would be combinatorial stimulation of Gi/o
responses in different subcellular domains. Thus, we investi-
gated whether or not we could activate the two opsins indepen-
dently and separately with two different wavelengths of light, i.e.,
blue and red light and tested the spectral sensitivity of vSWOand
vLWO in a heterologous expression system at different light in-
tensities (Figure 3). When using 1% light (i.e., 0.02 mW/mm2)
vSWO induced the maximal GIRK current response at 380 nm,
which is the shortest wavelength we could apply with our light
source. At wavelength longer than 510 nm light-induced GIRK
currents are <10% of maximal-induced current. In comparison,
vLWO maximally induced GIRK currents by wavelengths larger
than 450 nm and shows <20% of the light-induced GIRK current
at 380 nm (Figure 3A). The wavelength-dependent activation of
GIRK currents is also dependent on the light intensities, in partic-
ular for vLWO, being more specific at low (0.002 mW/mm2) and
high (2 mW/mm2) light intensities (Figure 3B). Thus, it is possible
to activate GIRK currents by two different wavelengths of light at
different light intensities using vSWO and vLWO. vSWO has a
higher wavelength specificity than vLWO.
Wavelength-Specific Control of Hyperpolarization in
DRN Neurons of Brain Stem Slices
In order to achieve sufficient light activation of the Gi/o pathway
in a specific receptor domain in neurons we tagged both
opsins with the CT of the 5-HT1A receptor (vLWO5-HT1A and
vSWO5-HT1A). Recently, we showed that tagging vRh with the
5-HT1A receptor CT targets and functionally substitutes for
5-HT1A receptors (Oh et al., 2010). To investigate if vertebrate
opsins are superb optogenetic tools to investigate intracellular
signaling pathways in neurons, we expressed vLWO5-HT1A and
vSWO5-HT1A in neurons of the dorsal raphe (Figures 4 and 5).
We created AAV2 viruses for expression of the two opsins in
mouse brain and injected the virus into the DRN of mice, a nuclei
with high concentration of serotonergic and GABAergic neurons.
5-HT1A receptors in the DRNmodulate neuronal firing via acti-
vation of GIRK current induced membrane hyperpolarization
(Maejima et al., 2013). We therefore investigated if vSWO5-HT1A
and vLWO5-HT1A induce hyperpolarization of DRN neurons
when activated by light and if light-induced hyperpolarization is
wavelength-specific. Indeed, vSWO5-HT1A- and vLWO5-HT1A-
expressing neurons hyperpolarize within a second by 10 mV
when a 2 s light pulse (1 mW/mm2) of 400 nm or 590 nm is
applied, respectively (Figures 4A and 4B). The amount of light-
induced hyperpolarization is comparable to the hyperpolar-
ization induced by 5-HT (Figures 4A and 4B). In addition, the
light-induced hyperpolarization is opsin- and wavelength-spe-
cific, because vSWO5-HT1A expressing neurons do not respond
to red light, and vLWO5-HT1A expressing neurons do not respond
to blue light. The light-induced hyperpolarization can be elicited
various times during the slice recordings (Figure S5). Light-
induced hyperpolarization occurs within a second, and repolar-
ization to resting membrane potential after light is switched off
Figure 4. Wavelength Specificity of Light-
Induced Hyperpolarization of DRN Neurons
by vLWO5-HT1A and vSWO5-HT1A
(A) Example traces of 5-HT and light-induced hy-
perpolarization of DRN neurons for control neu-
rons (top), vSWO5-HT1A (middle), and vLWO5-HT1A
(bottom) after a 2 s light pulse (1 mW/mm2) to
400 nm and 590 nm light. vSWO5-HT1A hyperpo-
larizes DRN neurons only when activated with
400 nm but not 590 nm light, while vLWO5-HT1A
hyperpolarizes DRN neurons only when activated
by 590 nm but not 400 nm light.
(B) Bar graph of the amount of 5-HT (100 mM) or
light-induced hyperpolarization during a 2 s light
pulse of the indicated wavelength or when no light
was applied ().
(C) Time course of light-induced hyperpolarization
and repolarization after the light pulse for
vSWO5-HT1A (light pulse 2 s 400 nm [1 mW/mm
2])
and vLWO5-HT1A (light pulse 2 s 590 nm [1 mW/
mm2]) expressing neurons. Time constants (t)
were determined by a single exponential fit.
(D) Current traces elicited in DRN control and
vSWO5-HT1A expressing neurons by a 500 ms long
voltage ramp from 120 to 35 mV before and
after 5-HT (100 mM) application or light activation.
Left: 5-HT (top) or 400 nm light pulse (bottom)
during the 500 ms voltage ramp increases the
membrane current. Right: subtraction of the cur-
rents before and after 5-HT application or light
activation shown on the left reveal an inward
rectifying current (most likely mediated by GIRK).
(E) Quantification of the light-induced current
measured at 110 mV.
(F) Inward current measured at 110 mV before
5-HTor light application in control and vSWO5-HT1A
expressing DRN neurons. Numbers in parenthesis
indicate the numbers of experiments. Values are
given as mean ± SEM; **p < 0.01 ANOVA.
See also Figure S5.
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Control of Gi/o Signaling by Cone Opsinstakes20 s (Figure 4C). We next investigated if light-induced hy-
perpolarization is mediated via light activation of a rectifying cur-
rent. We concentrated here on vSWO5-HT1A, which we used later
for the behavioral experiments (see below). Light activation of
vSWO5-HT1A expressed in DRN neurons induced an inward recti-
fying current (most likely GIRK current) of 75 pA at 110 mV
(Figures 4D and 4E), which is comparable to the current acti-
vated by application of 100 mM 5-HT. Most importantly, the in-
ward current at 110 mV before light, the resting membrane
potential, the input resistance, and the capacitance is compara-
ble between vSWO5-HT1A expressing and noninfected control
DRN neuron (Figure 4F; Table S1) suggesting that vSWO5-HT1A
has a low dark activity and does not change the physiological
properties of the neurons.
Repetitive Modulation of Neuronal Firing In Vivo
We next investigated if vertebrate opsins can be used to control
Gi/o signals in vivo. 5-HT1A receptors act as autoreceptors within
serotonin neurons as well as heteroreceptors in nonserotonin
neurons, such as GABAergic neurons in the DRN to modulate
firing of serotonergic neurons (Beck et al., 2004; Gocho et al.,2013; Kirby et al., 2003). Thus, depending in which cell-type
the Gi/o pathway is activated either a decrease in firing (direct
recording of Gi/o activation in most likely serotonergic or
GABAergic neurons) or an increase in firing (indirect recording
of neurons where GABAergic input is inhibited via the Gi/o
pathway) can be expected. Indeed, expression of vLWO5-HT1A
or vSWO5-HT1A within 5-HT1A receptors expressing dorsal raphe
neurons (Figures 5A1, 5A2, 5F1, and 5F2) and subsequent light
stimulation leads to either an increase (Figures 5B1, 5E1,
and 5E2) or decrease (Figures 5B2, 5D1, and 5D2) in the firing
rate of recorded neurons. Light activation leads to a 40%
(vSWO5-HT1A) or 90% (vLWO5-HT1A) decrease in action potential
firing of most likely serotonergic neurons in the DRN (Figures 5D1
and 5D2) or to a 2-fold increase in firing (vSWO5-HT1A and
vLWO5-HT1A, Figures 5E1 and 5E2). Action potential firing could
be repetitively controlled by 10 s or 30 s long light stimulation
(Figures 5B1 and 5B2) without decline in response efficiency
(Figures 5C1, 5C2, and S6). After light stimulation, firing recovers
to control levels (Figures 5D1, 5D2, 5E1, and 5E2). Thus,
vSWO5-HT1A and vLWO5-HT1A can be used for repetitive Gi/o
pathway activation in vivo without any decline in response.Neuron 81, 1263–1273, March 19, 2014 ª2014 Elsevier Inc. 1267
Figure 5. Repetitive Modulation of Neuronal Firing by vLWO5-HT1A and vSWO5-HT1A In Vivo
(A1 and A2) Functional expression of (A1) vSWO5-HT1A and (A2) vLWO5-HT1A in neurons of the dorsal raphe. Aq, aqueduct; DRD, dorsal raphe nucleus dorsal part;
DRI, dorsal raphe nucleus interfascicular part; DRV, dorsal raphe nucleus ventral part; DRVl, dorsal raphe nucleus ventrolateral part; mlf, medial longitudinal
fasciculus. Scale bar represents 100 mm.
(B1 and B2) Example trace of repetitive modulation of in vivo neuronal firing by light activation of (B1) vSWO5-HT1A and (B2) vLWO5-HT1A in anesthetized mice. Light
intensity at the tip of the optrode was 0.5–1 mW/mm2.
(C1 and C2) Relative change in firing frequency induced by light stimulation of (C1) vSWO5-HT1A and (C2) vLWO5-HT1A in vivo over five trials (number of cells; n = 5).
Note there is no significant differences between the light-induced change in firing frequencies during the five trials. Light intensity at the tip of the optrode was
0.5–1 mW/mm2.
(D1 and D2) Light-induced inhibition of neuronal activity by (D1) vSWO5-HT1A and (D2) vLWO5-HT1A. Percent change in firing frequency induced by light stimulation
in vivo. Light intensity at the tip of the optrode was 0.5–1 mW/mm2.
(E1 and E2) Light-induced excitation of neuronal activity by (E1) vSWO5-HT1A and (E2) vLWO5-HT1A. Percent change in firing frequency induced by light stimulation
in vivo. Note that no change in firing frequency was observed for noninfected and mCherry infected DRN neurons. Numbers in parenthesis indicate the numbers
of cells. Light intensity at the tip of the optrode was 0.5–1 mW/mm2.
(F1 and F2) vSWO5-HT1A and vLWO5-HT1A are colocalized with native 5-HT1A receptors in DRN neurons. Distribution of endogenous 5-HT1A receptors in the DRN.
Left: immunoreactivity for thenative5-HT1A receptor (F1, green) and (F2, red) and (F1) vSWO5-HT1A (red,mCherry) and (F2) vLWO5-HT1A (green, eGFP).Middle: overlay
of 5-HT1A immunoreactivity and (F1) vSWO5-HT1A and (F2) vLWO5-HT1A expressed in DRN neurons reveal that vSWO5-HT1A and vLWO5-HT1A are localized to 5-HT1A
positive neurons and colocalizes with the endogenous 5-HT1A receptors. Scale bars represent 50 mm. Right: highermagnification image of boxed area. Scale bars
represent 10 mm. Numbers in parenthesis indicate the numbers of experiments. Values are given as mean ± SEM; *p < 0.05, **p < 0.01, ***p < 0.001 ANOVA.
See also Figure S6.
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Control of Gi/o Signaling by Cone OpsinsOptogenetic Control of Anxiety Behavior by Vertebrate
Opsin vSWO5-HT1A in the Dorsal Raphe of Mice
We finally tested if light activation of the vertebrate opsin (i.e.,
vSWO5-HT1A) is sufficient to control behavior in awake, freely
moving mice. Serotonergic neurons of the DRN are involved in
controlling emotional behaviors such as anxiety and aggression.1268 Neuron 81, 1263–1273, March 19, 2014 ª2014 Elsevier Inc.VariousGPCRs such as the 5-HT1A or GABAB coupling to theGi/o
pathway are involved in the autoregulation and heteroregulation
of 5-HT release in the DRN (Maejima et al., 2013).We examined if
light activation of vSWO5-HT1A in 5-HT1A receptor domains would
be sufficient to control anxiety-related behavior, i.e., open-field,
elevated plus-maze, and novelty-suppressed feeding. When
Figure 6. Optogenetic Control of Anxiety
Behavior by Vertebrate Opsin, vSWO5-HT1A,
in the Dorsal Raphe of Mice
(A) Example of the functional expression of
vSWO5-HT1A in the dorsal raphe of mice. Aq, aque-
duct; DRD, dorsal raphe nucleus dorsal part; DRI,
dorsal raphe nucleus interfascicular part; DRV,
dorsal raphe nucleus ventral part; DRVl, dorsal
raphe nucleus ventrolateral part; mlf, medial longi-
tudinal fasciculus. Scale bar represents 100 mm.
Stars represent threedifferentmice,which received
a virus injection into the dorsal raphe nucleus and
indicate expression sites within the dorsal raphe.
(B) Open-field test (OF). Time in center (s) for each
individual trial without light stimulation (off) and
during light stimulation (on). In control mice no
significant differences (n.s.) between center time
without or during light stimulation were evident.
(C) Difference in time spent in center of the open-
field after light is switched on between control
mice and mice expressing vSWO5-HT1A (mean ±
SEM; **p < 0.01).
(D) Motor effects are not responsible for increased
center time. No significant differences in the
total distance moved with or without light stimu-
lation were observed between mice expressing
vSWO5-HT1A and control mice. In each group
(control and vSWO5-HT1A) three mice were
analyzed and each mouse was analyzed in three
independent trials.
(E) Novelty-suppressed feeding test (NSF). La-
tency to feed (s) is much shorter during light
stimulation in mice expressing vSWO5-HT1A (n = 6)
in comparison to control mice (n = 4).
(F) The food consumption (g) is not different during
light stimulation between vSWO5-HT1A expressing
mice (n = 6) and control mice (n = 4). Values are
given as mean ± SEM; **p < 0.01 ANOVA.
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Control of Gi/o Signaling by Cone Opsinstested in the open-field, light activation of vSWO5-HT1A within the
dorsal raphe nucleus (DRN) increased the time spent in the cen-
ter of the arena significantly (p < 0.01) in comparison to control
mice (Figures 6A–6C). The increase in center time during activa-
tion of the vSWO5-HT1A is not due to changes in motor perfor-
mance, because the overall distance traveled is not significantly
different (Figure 6D). In the novelty-suppressed feeding, light acti-
vation of vSWO5-HT1A reduced the latency to feed with no change
in foodconsumption (Figures6Eand6F). Incontrast, nodifference
in behavior in the elevated plus-maze experiments during light
stimulation of vSWO5-HT1A could be detected (data not shown).
The results suggest that activation of the Gi/o pathway in cellular
compartments where 5-HT1A receptors are located in the DRN
regulate certain aspects of anxiety behavior. Thus, vertebrate op-
sinsareoutstandingoptogenetic tools for controllingneuronalGi/o
signaling and to modulate Gi/o signaling in Gi/o-coupled receptor
domains to investigate emotional behavior in mice.
DISCUSSION
Vertebrate Opsins Are Tools for Precise Control of Gi/o
Signals in Mouse Brain
In recent years, variousmethods have been developed to control
GPCR pathways. These include optogenetic approaches usingvertebrate and invertebrate rhodopsin/opsins, chemical ap-
proaches such as DREADDs and RASSLs, and most recently,
chemico-optogenetic approaches such as LimGluR (Levitz
et al., 2013; Masseck et al., 2011). DREADDs, RASSLs, and
LimGluR have the advantage that most likely coupling and acti-
vation of G protein signals is receptor-type-specific. However, a
detailed analysis of which pathways are actually activated in
subcellular areas of neurons and if these are receptor specific
has not been demonstrated. DREADDs, RASSLs, and LimGluRs
are activated by synthetic ligands, which have to be applied to
living animals either by injection or feeding. In the case of
DREADDs and RASSLs, the GPCR activation and deactivation
is therefore difficult to control on a fast timescale. LimGluRs,
which are activated by a light-activatable, tethered synthetic
ligand can be controlled precisely and reliably by light (Levitz
et al., 2013). LimGluRs will have a great potential for deciphering
receptor function, when knockin animals are produced to intro-
duce the tethering site into the native GPCR. LimGluRs still
have the disadvantage that synthetic ligands are needed to
obtain functional light-driven receptors.
In comparison to the chemical and chemico-optogenetic
approaches, vertebrate rhodopsins/opsins have the advantage
that no ligand has to be applied when expressed for example
in the mammalian brain. The light-activated GPCRs seem to beNeuron 81, 1263–1273, March 19, 2014 ª2014 Elsevier Inc. 1269
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Control of Gi/o Signaling by Cone Opsinsreloaded with 11-cis retinal during repetitive stimulation, an
effect that has been observed early in HEK293 cells (Bruegge-
mann and Sullivan, 2002). Up to this point, the disadvantage of
rhodopsin has been the decline in G protein signal amplitude
(tested for GIRK channel activation) and its slow deactivation ki-
netics (Levitz et al., 2013). However, by using vertebrate opsins,
we could repetitively activate K+ conductances in HEK293 cells
and modulate neuronal activity in brain slices and in vivo without
a decline in response amplitude with fast activation and deacti-
vation kinetics, which are similar to signal activation by endoge-
nous GPCRs and with much lower light intensities than the
ultrasensitive channelrhodopsin variant CatCh and the halorho-
dopsin variant eNpHR3.0 (Gradinaru et al., 2010; Kleinlogel
et al., 2011). It has been estimated that the G protein activation,
as well as the deactivation of the signaling cascade, is much
faster in cones than in rods. The fast deactivation is most likely
related to the fact that phosphorylation of the activated GPCRs
is 50 times higher in cones than that in rods (Kawamura and
Tachibanaki, 2008). These mechanisms most likely contribute
to the fast recovery from light responses in cones and may
also contribute to the differences in signal termination by arrest-
ins andG protein-coupled receptor kinases (GRKs) between vRh
and vOpsins in other cell types. Fortunately, arrestin and GRK
isoforms are expressed ubiquitously. For example, HEK293 cells
express mRNAs of arrestin b1,2 and GRK3,4 (Atwood et al.,
2011) (Figure S3) and embryonic dorsal raphe neurons express
mRNA of arrestin b1,2 and GRK5/6 (Wylie et al., 2010). In addi-
tion, both cell types express rhodopsin like class A GPCRs.
Therefore, it is very likely that signal termination of vRh and
vOpsins in HEK293 cells and neurons involves the recruitment
of endogenous arrestin and GRK isoform. Arrestins are also
important for regeneration of the aporeceptor with 11 cis-retinal
(Sommer et al., 2012). In addition, the half-time of release of
retinal from vSWO is 250-fold faster than that of rhodopsin
(Chen et al., 2012). Thus, the faster deactivation of the light
response as well as the faster release of retinal in cone opsins
most likely contribute to the faster deactivation kinetics and
the stable response amplitude of the cone opsins in comparison
to the rod rhodopsins when expressed in HEK cells or neurons.
One important difference between the different cone and rod
pigments is that they are maximally activated at different wave-
length of light. The mouse and human vSWO and vLWO opsins,
which we used in our study, have excitation peaks at 360 nm and
550–560 nm, respectively (Ebrey and Koutalos, 2001). In order to
investigate the possibility to activate different G protein signals at
different wavelengths of light, we first tested the wavelength-
dependence of GIRK channel activation in HEK cells when either
vSWO or vLWO are coexpressed. We found that vSWO maxi-
mally activates GIRK current at 380–400 nm while vLWO acti-
vated GIRK currents between 550–650 nm. Both receptors
activate GIRK currents to <45% (vLWO) or 18% (vSWO) of its
maximal amplitude at wavelength shorter (vLWO) or longer
(vSWO) than the maximal excitation peaks. This activation of
GIRK currents at shorter wavelength for vLWO most likely re-
flects the relative absorbance of the visual pigments at lower
wavelength (Nikonov et al., 2006). The wavelength specificities
of the opsins are light intensity-dependent becoming more spe-
cific at lower (0.002 mW/mm2) and higher (2 mW/mm2) light in-1270 Neuron 81, 1263–1273, March 19, 2014 ª2014 Elsevier Inc.tensities. In fact, in the brain slice recordings, light-induced
hyperpolarization was wavelength-specific (1 mW/mm2). Hyper-
polarization could only be induced by blue but not red light in
vSWO5-HT1A expressing neurons and by red but not blue light
in vLWO5-HT1A expressing neurons. Most importantly, dark
activity of at least vSWO5-HT1A is very low, because no differ-
ences in the inward current at 110 mV was detected between
vSWO5-HT1A-expressing and control neurons in the absence of
light. Thus, the combinatorial use of vLWO and vSWO gives
the opportunity to control different Gi/o receptor responses in
subcellular receptor domains in vitro and in vivo, in particular
when light-dependent GPCRs are targeted to different subcellu-
lar structures.
Activation of Gi/o Signals in 5-HT1A Receptor Domains by
Vertebrate Opsins in the Dorsal Raphe Nuclei Reduces
5-HT Firing and Relieves Anxiety in Mice
A change in 5-HT levels in the brain has been associated with
various behavioral changes including anxiety and suppression of
5-HT1A autoreceptors and/or constitutive knockout of 5-HT1A in-
crease anxiety behaviors in mice (Gross et al., 2000; Heisler
et al., 1998; McDevitt and Neumaier, 2011; Parks et al., 1998;
Ramboz et al., 1998; Richardson-Jones et al., 2011). We there-
fore tested if anxiety behavior can be modulated by activation
of Gi/o signals in the DRN in 5-HT1A receptor domains as would
be expected from the anxiolytic effects of infusion of 5-HT1A re-
ceptor agonists in the DRN (Graeff et al., 1998; Higgins et al.,
1988, 1992; Hogg et al., 1994; Remy et al., 1996; Romaniuk
et al., 2001). Increasing evidence suggest that besides their
prominent role as autoreceptors, 5-HT1A receptors expressed
in non-5-HT neurons, such as GABAergic interneurons con-
nected to 5-HT neurons in the DRN, also contribute to the mod-
ulation of serotonergic firing (Beck et al., 2004; Gocho et al.,
2013; Kirby et al., 2003; Sharp et al., 2007). Indeed, activation
of vSWO tagged with the CT from 5-HT1A receptors relieves
anxiety inmice in the open-field and novelty-suppressed feeding
test but not in the elevated plus-maze. Our results are in
agreement with behavioral analysis of conditional suppression
of 5-HT1A autoreceptors in serotonergic neurons. The condi-
tional suppression of the 5-HT1A increases anxiety behavior in
the open field and novelty-suppressed feeding, but not in the
elevated plus-maze (Richardson-Jones et al., 2010, 2011). The
different behavioral assays most likely test different aspects of
anxiety such as exploration of aversive environments and
stress-induced anxiety and suggest that certain aspects of anx-
iety behavior are regulated by Gi/o signals/5-HT1A receptors in
the DRN.
This is a demonstration that a light-controlled Gi/o pathway
can modulate certain aspects of anxiety behavior. Thus, the
targeting of light-gated GPCRs into specific receptor domains,
its activation of a specific G protein pathway in combination
with cell-type-specific expression such as serotonergic neu-
rons or GABAergic neurons will elucidate signaling mecha-
nisms in the raphe nuclei in relation to emotional behavior
in future studies. Because the activation of Gi/o pathway in
DRN neurons relieves certain aspects of anxiety, this light-
gated GPCR approach might be applicable for new therapeutic
strategies.
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Generation of Plasmid Constructs
Mouse blue opsin (vSWO) and human red opsin (vLWO) cDNA (GenBank
accession numbers OPN1SW U49720 and OPN1LWNP_064445.1) clones
were tagged C-terminally with mCherry or eGFP immediately after the last
coding codon using fusion PCR. Forward primers containing the restriction
site NheI and Kozak sequence were: 50-GCTAGCACCATGGCCCAGCAGTG
GAGCCTCCAAAGGCTC-30 and 50-GCTAGCACCATGTCAGGAGAGGATGAC
TTTTACCTGTTT-30 and reverse primers 50-CCGCGGTGCAGGCGATACCG
AGGACACAGATGAGAC-30 and 50-CCGCGGGTGAGGGCCAACTTTGCTAGA
AGAGACAGT-30. To construct AAV-expression vectors, pAAV-MCS vector
(Stratagene) was modified using the Gateway Vector Conversion System
(Invitrogen). Briefly, cassette A (Invitrogen) was inserted into the HincII restric-
tion site via blunt-end ligation to create a gateway destination vector. Entry
clones were generated by cloning the gene of interest into pENTR/D-TOPO
shuttle vector according to the manufacturer’s protocol (forward primer for
directional cloning into pENTR/D-TOPO: vLWO 50-CACCATGGCCCAGCAG
TGGAGCCTCCAAAGGCTC-30 and vLWO: 50-CACCATGTCAGGAGAGGATG
ACTTTTACCTGTTT-30). The reverse primer was created against the last cod-
ing nucleotide of mCherry or eGFP, respectively, (mCherry: 50-CTACTTGTAC
AGCTCGTCCATGCCGCC-30 or eGFP: 50-CTACTTGTACAGCTCGTCCATGC
CGAG) or with the addition of the ER Export Motif and the C terminus of the
5-HT1A receptor and a STOP-Codon (reverse primer vLWO1A: 5
0-CTAATT
AATTTGCATAGCTCATCCATCCCTCCAGTAGAATGTCGTCGTCCCTCACAC
CTCGTTCTCGTACTCGCAGAACTTGTACAGCTCGTCCATGCCGAG-30 and
vSWO1A: 5
0-CTAATTAATTTGCATAGCTCATCCATCCCTCCAGTAGAATGTC
GTCGTCCCTCACACCTCGTTCTCGTACTCGCAGAACTTGTACAGCTCGTCC
ATGCCGCC-30). LR recombination was performed to create final AAV expres-
sion clones. Expression constructs vRh-mCherry are described in Oh et al.
(2010).
Cell Culture and Infection
Cell culture and maintenance of human embryonic kidney 293 (HEK293) cells
were performed as described previously (Wittemann et al., 2000). Stably ex-
pressing GIRK1/2 subunits HEK293 cells (kindly provided by Dr. A. Tinker,
UCL London) were transfected with Lipofectamine2000 (Invitrogen) and incu-
bated for 18–24 hr before recordings.
AAV2 Virus Production, Surgery, Virus Injection, and Cannula
Placement
Recombinant adeno-associated virus stocks serotype 2 were produced either
according to theAAVHelper-FreeSystemmanual (Stratagene) orby theplasmid
cotransfection method (Choi et al., 2007) and purified via iodixanol gradient ul-
tracentrifugation. Purified viruswasbuffer exchanged against PBSwith 0.001%
Tween and concentrated. DNase-resistant viral genomes were titered by quan-
titativePCR relative to standards (Aurnhammer et al., 2012). AAV2 injections into
the dorsal raphe nuclei: AAV2 viruses expressing vSWO5-HT1A and vLWO5-HT1A
were injected into the dorsal raphe nucleus (DRN) of wild-type (C57Bl/6J) mice.
Mice 2–3 months of age were anesthetized with ketamine/xylazine (ketamine
10 mg/kg; xylazine 20 mg/kg) and placed into a stereotactic frame. Body tem-
perature was controlled with a heating pad. A sagittal incision along themidline
was made to expose the cranium, a burr hole was drilled at lambda and 0 mm
lateral, and at a depth between 2,000–1,500 mm virus was injected in 100 mm
steps.Viruswaspressure injectedbyacustomizedglassmicropipette (tipdiam-
eter10mm). For implantations, a customized cannula guide (PlasticsOne) was
lowered into the brain after the virus injection and secured to the scull with the
use of dental cement (Charisma). To avoid contamination of cannula guides,
dummy cannulae (Plastics One) were inserted. At the end of implantation, the
skin was sutured with surgical yarn. After the surgery, animals received subcu-
taneous injections of carprofen (2 mg/kg) for analgesia. Animals were placed
individually into their home cages and allowed to recover for at least 14 days
before performing electrophysiological or behavioral experiments.
In Vitro Electrophysiology and Data Analysis
For GIRK channel recordings in HEK293 cells, light-sensitive GPCRs were ex-
pressed in HEK293 cells stably expressing GIRK1/2 subunits. Cells werecultured and recorded in dark room conditions after transfection. GIRK-medi-
ated K+-currents were measured and analyzed as described previously (Li
et al., 2005). The external solution was as follows: 20 mM NaCl, 120 mM
KCl, 2 mM CaCl2, 1 mM MgCl2, 10 mM HEPES-KOH, pH 7.3 (KOH). Patch pi-
pettes (2–5 megaohm) were filled with internal solution: 100 mM potassium
aspartate, 40 mM KCl, 5 mM Mg ATP, 10 mM HEPES-KOH, 5 mM NaCl,
2 mM EGTA, 2 mM MgCl2, 0.01 mM GTP, pH 7.3 (KOH). Cells were recorded
in external solution containing 1 mM 9-cis-retinal (Sigma). Cells were visualized
using a trans-illuminated red light (590 nm) or blue light filter (450 nm) during
experimental manipulations. Whole-cell patch clamp recordings of HEK293
cells were performed with an EPC9 amplifier (HEKA). Currents were digitized
at 10 kHz and filtered with the internal 10-kHz three-pole Bessel filter (filter
1) in series with a 2.9 kHz 4-pole Bessel filter (filter 2) of the EPC9 amplifier. Se-
ries resistances were partially compensated between 70%and 90%. Leak and
capacitive currents were subtracted by using hyperpolarizing pulses from
60 mV to 70 mV with the p/4 method.
Brain Slice Recordings
Coronal slices including dorsal raphe (250 mm thick) were cut from brainstems
of the mice 14–21 days after AAV2 injection and recordings were performed
according to Oh et al. (2010). Briefly, mice were anesthetized with isoflurane
and decapitated. The brainstem was sliced in ice-cold solution containing
87 mM NaCl, 75 mM sucrose, 2.5 mM KCl, 0.5 mM CaCl2, 7 mM MgCl2,
1.25 mM NaH2 PO4, 25 mM NaHCO3, and 20 mM glucose bubbled with
95% O2 and 5% CO2 using with a vibratome (VT1000S, Leica). Slices were
stored for at least 1 hr at room temperature in a recording artificial cerebrospi-
nal fluid containing 124 mM NaCl, 3 mM KCl, 2.5 mM CaCl2, 1.2 mM MgSO4,
1.23 mM NaH2 PO4, 26 mM NaHCO3, and 10 mM glucose bubbled with 95%
O2 and 5%CO2. Fluorescent mCherry or GFP-positive cells were visually iden-
tified under an upright microscope (DMLFSA, Leica) equipped with a mono-
chromator system (Polychrome IV, TILL Photonics) flashing excitation light
(light intensity, 1mW/mm2).Whole-cell recordings weremade at room temper-
ature in the dark except for using infrared light to target the cell. Slices were
preincubated at least 20 min and continuously perfused with the external
solution including 25 mM 9-cis-retinal, 0.025% (±)-a-tocopherol (Sigma),
0.2% essentially fatty acid-free albumin from bovine serum (Sigma), and
0.1% dimethyl sulfoxide. Patch pipettes (2–4 megaohm) were filled with an in-
ternal solutionwith the composition 125mMpotassium gluconate, 4mMNaCl,
2 mM MgCl2 10 mM HEPES, 0.2 mM EGTA, 4 mM Mg-ATP, 0.4 mM Na-GTP,
and 10mM Tris-phosphocreatine, pH 7.3 (KOH). Membrane currents and volt-
ages were recorded with an EPC10/2 amplifier (HEKA). The signals were
filtered at 3 kHz and digitized at 50 kHz. The PatchMaster software (HEKA)
was used for the controls of voltage and data acquisition, and off-line analysis
was made with Igor Pro 6.0 software (Wavemetrics).
In Vivo Extracellular Recordings and Optical Stimulation
For extracellular in vivo recordings, anesthetized mice were placed in a stereo-
tactic frame. Optrodes consisted of an optical fiber with 200 mm diameter
(Thorlabs, BFL37-200) fused to a customized glass-coated tungsten recording
electrode (2–3 MU). Optrodes were coupled to a blue diode-pumped laser
(l = 473 nm; 20 mW; CL 2000 crystal laser) for light delivery. Light intensity
at the tip of the optrode was 0.5–1 mW/mm2. Single- and multiunit potentials
were amplified and filtered (Gain 10 kHz; 300 Hz-10 kHz band-pass; A-M
Systems, model 1800). After noise elimination (50/60 Hz Noise Eliminator,
Quest Scientific), potentials were stored with a sampling rate of 20 kHz using
a 1401 Power mk interface (CED) and analyzed offline using Spike2 software.
One trial lasted 70 or 90 s, including 30 s baseline recordings, 10 or 30 s light
stimulation, followed by additional 30 s baseline recordings. Five to ten trials
were recorded for each cell. Data analysis was done offline by a customized
MATLAB program and Igor 6.0 (Wavemetrics). Statistical significance
throughout the experiments was tested with ANOVA. For immunohistology
and immunohistochemistry, adult mice were deeply anesthetized before
transcardial perfusion with 4% paraformaldehyde in 0.1 M PBS for 20 min.
The brain was then removed and postfixed in paraformaldehyde for another
1 hr at room temperature followed by cryoprotection in 30% sucrose (w/v)
overnight at 4C. Tissue sections (30 mm) were prepared on a cryostat and
mounted on Superfrost Plus Microscope Slides (Fisher). Tissue sectionsNeuron 81, 1263–1273, March 19, 2014 ª2014 Elsevier Inc. 1271
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Biotechnology), and then Alexa 488 (in combination with vSWO5-HT1A)-conju-
gated or Alexa 594 (in combination with vLWO5-HT1A)-conjugated secondary
antibody (1:800, Life Technology). Fluorescent images were imaged at a Leica
TCS SP5II confocal microscope.
Open-Field Test
For the open-field test mice, 10–12 weeks of age, were injected stereotacti-
cally with vSWO5-HT1A into the DRN and implanted as described above.
Mice were individually caged and allowed to recover for at least 14 days.
Animals were moved from the holding room to the behavior room at least
1 hr prior to testing. Control mice were implanted only, received a virus injec-
tion into a different brain area, or showed no expression of vSWO5-HT1A at all.
The open-field arena consisted of an acrylic chamber (30 3 30 3 30 cm,
Noldus Information Technology), subdivided into 4 3 4 equal grids. The inner
four squares (14.5 3 14.5 cm) were defined as the center region and the re-
maining squares were specified as border region. Mice were anesthetized
with isoflurane to facilitate withdrawal of the dummy cannula. Animals were
allowed to recover from isoflurane anesthesia for a minimum of 5 min. Optical
stimulationwas applied through a fiber-optic cannula (cannula: plastic one; op-
tical commutator: Doric lenses) targeting the DRN. Fibers were attached to a
patch cord (Doric lenses) coupled to a blue diode laser (CL 2000; 20mW, crys-
tal laser). Mice were placed into the center of the open-field and videos were
analyzed using automatic tracking software (EthoVision XT 8.5; Noldus) for
time spent in the center and total distance traveled. Eachmousewasmeasured
with the same protocol, comprising 3 min constant light stimulation alternating
with 3 min without optical stimulation, in three subsequent trials.
Novelty-Suppressed Feeding
Mice were deprived from food 24–27 hr prior testing with water available ad
libitum. Individual mice were coupled to a fiber patch cord for constant light
delivery under short isoflurane anesthesia as described previously and allowed
to recover from handling for 5 min. A familiar food pellet (weighing 2 g) was
placed on a filter paper (60 mm in diameter) into the middle of an arena
(30 3 30 3 30 cm), brightly illuminated with two 75 W incandescent bulbs.
Mice were placed into the corner of the arena covered with clean wood chips
and laser stimulation was applied as long as mice started to feed. The task
ended when themice first fed, defined as biting the food pellet with use of fore-
paws. Mice were removed from the arena, released from the fiber patch cord,
and placed into their homecage to measure food consumption for an addi-
tional 5 min.
All experiments were approved by the Institutional Animal Research Facility.
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